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GENOMIC PREDICTION

Genomic Prediction Enhanced Sparse Testing for
Multi-environment Trials
Diego Jarquin,*,1 Reka Howard,* Jose Crossa,†,‡,1 Yoseph Beyene,† Manje Gowda,†
Johannes W. R. Martini,† Giovanny Covarrubias Pazaran,† Juan Burgueño,† Angela Pacheco,†
Martin Grondona,§ Valentin Wimmer,** and Boddupalli M. Prasanna†
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ABSTRACT “Sparse testing” refers to reduced multi-environment breeding trials in which not all genotypes
of interest are grown in each environment. Using genomic-enabled prediction and a model embracing
genotype · environment interaction (GE), the non-observed genotype-in-environment combinations can be
predicted. Consequently, the overall costs can be reduced and the testing capacities can be increased. The
accuracy of predicting the unobserved data depends on different factors including (1) how many genotypes
overlap between environments, (2) in how many environments each genotype is grown, and (3) which
prediction method is used. In this research, we studied the predictive ability obtained when using a ﬁxed
number of plots and different sparse testing designs. The considered designs included the extreme cases of
(1) no overlap of genotypes between environments, and (2) complete overlap of the genotypes between
environments. In the latter case, the prediction set fully consists of genotypes that have not been tested at all.
Moreover, we gradually go from one extreme to the other considering (3) intermediates between the
two previous cases with varying numbers of different or non-overlapping (NO)/overlapping (O)
genotypes. The empirical study is built upon two different maize hybrid data sets consisting of different
genotypes crossed to two different testers (T1 and T2) and each data set was analyzed separately. For
each set, phenotypic records on yield from three different environments are available. Three different
prediction models were implemented, two main effects models (M1 and M2), and a model (M3)
including GE. The results showed that the genome-based model including GE (M3) captured more
phenotypic variation than the models that did not include this component. Also, M3 provided higher
prediction accuracy than models M1 and M2 for the different allocation scenarios. Reducing the size of
the calibration sets decreased the prediction accuracy under all allocation designs with M3 being the
less affected model; however, using the genome-enabled models (i.e., M2 and M3) the predictive
ability is recovered when more genotypes are tested across environments. Our results indicate that a
substantial part of the testing resources can be saved when using genome-based models including GE
for optimizing sparse testing designs.

Multi-environmental trials (METs) that allow assessing the performance of different candidate genotypes under varying environmental
conditions are essential components of breeding schemes. Estimating
genotype · environment (GE) interaction is important to identify
stable genotypes or genotypes with speciﬁc adaptation. The environments can be given by managed stress trials, but can also simply be
deﬁned by different locations without clear distinction between the
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types of conditions. Ideally, all genotypes under consideration should
be observed at each location to investigate the GE interactions of the
germplasm. This approach requires extensive ﬁeld-testing (Smith
et al. 2015a; Smith et al. 2015b).
In the last two decades, genome-based prediction of genetic values
(GP, Meuwissen et al. 2001) has revolutionized plant and animal
breeding (Hayes et al. 2009; Jannink et al. 2010; Crossa et al. 2010,
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2011; Crossa et al. 2017). GP uses dense molecular markers from the
entire genome to derive a genomic relationship matrix which can be
used to predict the performance of lines of known genotype but
unknown phenotype. GP has been used to increase selection accuracy
by using predictions as additional (multi-year or multi-location)
phenotypes (Jarquín et al. 2014a), to reduce the cycle length by
skipping certain stages (Crossa et al. 2017) or to reduce the experimental effort by using only testing subsets of the considered genotypes, thus increasing the evaluation capacity and, potentially, the
selection intensity.
The latter is of particular interest in the context of METs. Here,
predictions can reduce the experimental effort by using “sparse
testing” methods in which only a subset of the genotypes that we
wish to evaluate is tested at each location. The missing (unobserved)
genotype-in-environment combinations can be predicted from the
measured data. Sparse testing reduces the costs at a ﬁxed evaluation
capacity, or increases the overall evaluation capacity at ﬁxed costs,
thus leading to an increase in selection intensity or an increase in
accuracy by better coverage of the target population of environments
(TPE) and, potentially, increasing the selection gains. Here - as often
occurs when dealing with the breeder’s equation - we are facing a
trade-off between two components. The prediction may be less
accurate than a measured phenotype, but an increase in selection
intensity may compensate for the loss of accuracy by far and
ultimately lead to an overall increase in selection gain (Fehr 1987).
Therefore, a crucial question is which design (that is, how the
genotypes should be partitioned across environments) gives the best
relationship between accuracy and evaluation capacity.
The predictive ability of methods is usually evaluated using some
form of cross-validation (CV) that splits the observed data set into a
calibration (training) set and a prediction (testing) set, predicting the
phenotypic performance of the genotypes in the prediction set by
using the phenotypes of the calibration set. In order to evaluate
the model’s performance, the predicted values of the genotypes in the
prediction set are compared to their observed phenotypes. In the
context of structured data consisting of year cohorts with phenotypes
obtained in different environments, different types of CVs mimicking
potential applications are conceivable. For instance, Burgueño et al.
(2012) studied the prediction accuracy when predicting the performance of genotypes that had never been evaluated (named crossvalidation 1, CV1). For CV1, the phenotypic records of other
genotypes grown in the relevant environments are used as a calibration set. An alternative is cross-validation 2 (CV2) in which the
performance of some genotypes in speciﬁc environments is predicted
by a calibration set which includes records of the same genotype in
other environments. CV2 represents the problem of predicting a
certain portion of tested genotypes in a certain portion of tested
environments (incomplete ﬁeld trials).
These CV schemes (CV1, CV2) represent sparse testing designs with
different levels of overlapping genotypes. Sparse testing approaches are
particularly useful in early generation testing when a large number of
genotypes is available (Butler et al. 2014; Oakey et al. 2016). Here, a
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crucial question is how to design a multi-environmental trial system
that will optimize the trade-off between the selection intensity
(number of genotypes tested) and the accuracy of the predicted
values. Due to the generally limited resources, this leads to a resource
allocation problem for maximizing genetic gain at ﬁxed costs.
The aim of this study is to investigate how a set of genotypes can
be arranged across different environments, given a total number of
plots. We varied the number of overlapping genotypes with the
objective of improving the predictive ability of untested genotypeby-environment combinations. We studied the two extreme cases of
(1) non-overlapping genotypes between environments (NO) with
each line being observed exactly once across environments and (2) the
same set of genotypes being tested in all environments (“all overlapping”). Since the overall number of plots has been ﬁxed, all other
genotypes to be predicted have never been observed in any location
for scenario (2). Between these two extreme cases, we (3) varied the
number of non-overlapping (NO)/overlapping (O) lines. We used
two data sets of maize genotypes crossed with two testers: T1 and T2.
The two data sets (DST1 and DST2) created using testers T1 and T2
are not-overlapping in terms of the lines used for the crosses. In all
cases we ﬁtted three different prediction models as follows: (M1)
including only the environment and genotype main effects (no
molecular marker information nor any interaction was included);
(M2) environmental, genotype and genomic main effects; and
(M3) environmental, genotype, genomic main effects and GE
interaction.
MATERIALS AND METHODS
Maize experimental multi-environment data sets
For this study, we used two maize data sets from CIMMYT’s maize
breeding program in eastern Africa: DST1 comprised 843 unique
CIMMYT maize genotypes where 843 unique genotypes were crossed
with tester T1, while DST2 had 453 CIMMYT maize genotypes where
453 unique genotypes were crossed with tester T2. For both data sets,
genotypic data from 73,219 SNP markers were available. After
applying conventional quality control on the molecular markers
(SNPs with more than 50% missing values and with a minor allele
frequency lower than 3% were discarded), the number of SNP
markers that remained for analysis were 68,169 and 62,882 for
DST1 and DST2, respectively. The genotypes crossed with testers
T1 and T2 were different and the data sets have therefore been
considered separately.
Data sets DST1 and DST2 consist of hybrids created by the crosses
between the unique genotypes and the two testers T1 and T2. The
maize hybrids were evaluated in three environments in Kenya, of
which two represent optimal conditions and one drought stress. The
phenotypic correlations for DST1 were 0.08 and 0.07 between the
records of the drought environment and the two optimal locations,
and 0.12 between the records from the two optimal locations. The
corresponding values for DST2 were higher, with 0.37 and 0.13 for the
correlation between the drought environment and the two optimal
sites, and 0.30 between the two optimal locations.
Allocation designs for sparse testing
Sampling non-overlapping/overlapping methods for assessing sparse
testing: Suppose we are interested in DST1, where there are a total of
843 maize genotypes that need to be evaluated in three different
environments. However, due to budget limitations, the number of
plots that can be tested in the ﬁeld is limited because we cannot test
2,529 (843 · 3) plots representing all the genotypes in all three

Figure 1 Sparse design for allocating 843 plots
to be tested in three environments for 843 unique
genotypes with 281 non-overlapping/0 overlapping. Horizontal gray lines indicate the genotype-by-environment combinations that were
tested in each environment. The rows correspond to the genotypes (from 1 to 843) while
columns represent the environments (from Env
1 to Env 3).

environments. Then we need to decide whether to test one set of lines
across all environments (overlapping), multiple sets of lines within
environments (non-overlapping), or a mix between overlapping
and non-overlapping lines. We can differentiate between designs by
their fraction of numbers of non-overlapping (NO), and overlapping lines (O).
Let us assume that initially we are granted resources for phenotyping only 843 genotypes (1/3 of the total genotype/environment
combinations). Further, let us assume that the phenotyping costs are
the same in all environments; then the allocation problem is simpliﬁed and reduced to deciding how many genotypes will be observed
in the different environments.
We denoted the set of genotype-in-environment combinations
that are observed in the ﬁeld as the calibration set. For these
genotype-in-environment combinations we have marker and corresponding phenotypic information. We use this information to
calibrate the prediction model for predicting the remaining set of
untested genotypes-in-environment combinations. The genotypein-environment combinations for which we obtain the predictions
is the prediction set.

The different allocation designs depend on the number of NO/O
maize genotypes in each environment. The overlapping genotypes can be
considered as a bridge for connecting environments. In order to describe
the different designs, we show and explain examples in Figures 1-3 and
Table 1. Other scenarios may appear when there is a restriction with
respect to the number of genotypes to be tested in each environment.
Allocating 281 non-overlapping/0 overlapping genotypes: First, for
selecting the calibration set, suppose we decide to plant the same
number of genotypes per environment (281 = 843 / 3). The next issue
to consider is how to select and assign these genotypes to the
environments. For example, should we assign non-overlapping/overlapping genotypes across the environments? If so, how many? The
simplest design would include 3 non-overlapping sets of genotypes
leading to a calibration set of 281 genotypes in each of the three
environments (Figure 1). With this allocation design, we ensure that
each genotype will be tested (observed) in exactly one environment.
Hence, for each environment, the prediction set would be composed of
the remaining 562 (2 · 281) genotype-in-environment combinations
that were not observed.
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281
281/0
271
261
251
241
231
221
211
201
191
181
171
161
151
Cont. by column
281
141/140
271
141/130
261
141/120
251
141/110
241
141/100
231
141/90
221
141/80
211
141/70
201
141/60
Cont. by row
191
141/50
181
141/40
171
141/30
161
141/20
151
141/10

SS per Env
261/20
261/10
261/0

121/160
121/150
121/140
121/130
121/120
121/110
121/100
121/90
121/80
121/70
121/60
121/50
121/40
121/30

271/10
271/0

131/150
131/140
131/130
131/120
131/110
131/100
131/90
131/80
131/70

131/60
131/50
131/40
131/30
131/20

111/80
111/70
111/60
111/50
111/40

111/170
111/160
111/150
111/140
111/130
111/120
111/110
111/100
111/90

251/30
251/20
251/10
251/0

101/90
101/80
101/70
101/60
101/50

101/180
101/170
101/160
101/150
101/140
101/130
101/120
101/110
101/100

241/40
241/30
241/20
241/10
241/0

91/100
91/90
91/80
91/70
91/60

91/190
91/180
91/170
91/160
91/150
91/140
91/130
91/120
91/110

231/50
231/40
231/30
231/20
231/10
231/0

81/110
81/100
81/90
81/80
81/70

81/200
81/190
81/180
81/170
81/160
81/150
81/140
81/130
81/120

221/60
221/50
221/40
221/30
221/20
221/10
221/0

71/120
71/110
71/100
71/90
71/80

71/210
71/200
71/190
71/180
71/170
71/160
71/150
71/140
71/130

211/70
211/60
211/50
211/40
211/30
211/20
211/10
211/0

61/130
61/120
61/110
61/100
61/90

61/220
61/210
61/200
61/190
61/180
61/170
61/160
61/150
61/140

201/80
201/70
201/60
201/50
201/40
201/30
201/20
201/10
201/0

Testing set composition within environment non overlaping/overlaping

51/140
51/130
51/120
51/110
51/100

51/230
51/220
51/210
51/200
51/190
51/180
51/170
51/160
51/150

191/90
191/80
191/70
191/60
191/50
191/40
191/30
191/20
191/10
191/0

41/150
41/140
41/130
41/120
41/110

41/240
41/230
41/220
41/210
41/200
41/190
41/180
41/170
41/160

181/100
181/90
181/80
181/70
181/60
181/50
181/40
181/30
181/20
181/10
181/0

31/160
31/150
31/140
31/130
31/120

31/250
31/240
31/230
31/220
31/210
31/200
31/190
31/180
31/170

171/110
171/100
171/90
171/80
171/70
171/60
171/50
171/40
171/30
171/20
171/10
171/0

21/170
21/160
21/150
21/140
21/130

21/260
21/250
21/240
21/230
21/220
21/210
21/200
21/190
21/180

161/120
161/110
161/100
161/90
161/80
161/70
161/60
161/50
161/40
161/30
161/20
161/10
161/0

11/180
11/170
11/160
11/150
11/140

11/270
11/260
11/250
11/240
11/230
11/220
11/210
11/200
11/190

151/130
151/120
151/110
151/100
151/90
151/80
151/70
151/60
151/50
151/40
151/30
151/20
151/10
151/0

1/190
1/180
1/170
1/160
1/150

1/280
1/270
1/260
1/250
1/240
1/230
1/220
1/210
1/200

n■ Table 1 Testing composition combinations between non-overlapping and overlapping sets of lines for different sample sizes (SS) to be tested within environments for the case of
Maize Tester 1 (843 genotypes, partitioned into 281 non-overlapping set, tested in different environments)

Figure 2 Experimental design for allocating 843 plots to be tested in three environments for 281 unique genotypes. The
blue lines correspond to genotypes tested
across the three environments (columns).

Allocation design - 0 non-overlapping/281 overlapping genotypes:
The opposite extreme case of 281/0 is the case of 0/281. Here, a
common set of 281 genotypes is tested across environments (see
Figure 2). The prediction set consists of all genotype-in-environment
combinations of those genotypes not tested at all.
Allocating 241 non-overlapping/40 overlapping genotypes and other
designs: Another scheme may consider sets of common genotypes
across environments to allow connectivity across environments. In
this design, instead of having all genotypes tested in one environment,
we are going to observe 40 genotypes in all of the environments.
Figure 3 shows this scheme where a common set of genotypes (40) is
observed across environments (see blue lines). This leads to a
situation in which 40 genotypes are observed in all three environments, 723 (=3 · 241) genotypes are observed in only one environment and 80 genotypes are not observed at all. It means that
241 unique genotypes are observed in environment 1, another set
of 241 unique genotypes are observed in environment 2, and a third

set of 241 unique genotypes are observed in environment 3. The total
number of plots to observe is 3 · 40 (common in the three
environments) + 3 · 241 (different in the three environments) =
843. Therefore, the calibration set consists of these 843 genotype-inenvironment combinations, while across environments, the prediction set consists of the remaining 843 · 2 combinations (shown in
Figure 3). Table 1 provides a listing of the combinations considered
for DST1 for different sample sizes and ﬁxed number of plots for
prediction sets (562 = 2 · 281). For each one of the rows in Table 1,
25 different initial random partitions (repetitions) were performed
for the cases 281/0, 271/0, . . .,141/0; then the NO/O designs were
gradually varied by sets of 10 genotypes.
STATISTICAL MODELS
Phenotypic adjustment
Best Linear Unbiased Estimators (BLUEs) of the genotypes were
computed using ASReml for R for mixed model analysis (Gilmour
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Figure 3 Experimental design for allocating 843 plots to be tested in three environments for 843-80 = 763 unique genotypes.
Horizontal gray lines indicate that these
genotypes were tested in the corresponding environments (columns). Blue lines correspond to genotypes (40) tested across
environments.

et al. 2009) of grain yield in each environment. The model used to
calculate these BLUEs for each environment was
yjkl ¼ m þ Lj þ rk þ dlðrÞ þ ejkl ;
where yjrm represents the phenotypic trait analyzed (grain yield), Lj is
the ﬁxed effect of the jth genotype/line, rk is the random effect of the
kth replicate that is independently, identically (iid), and normally
distributed such that r ¼ frk g  N(0, Is2r ) (where I is the identity
matrix and s2r is the variance among replicates), dlðrÞ denotes the
effect of the lth incomplete block within the rth replicate assumed to be
iid and normally distributed such that d ¼ fdlðrÞ g  N(0, Is2lðrÞ )
with s2lðrÞ being the variance of the incomplete block within the
replicate, ejkl is the random error assumed to be iid and also normally
distributed such that e ¼ fejkl g N(0, Is2e ), where s2e denotes the
error variance.
To implement the GP analysis, we used the reaction norm model
(Jarquín et al. 2014b), which is an extension of the random effect
Genomic Best Linear Unbiased Predictor (GBLUP) model where the
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main effect of genotypes, the main effect of environments, the main effect
of markers, and their interactions are modeled using random covariance
structures that are functions of the genomic and environmental covariates. Brief descriptions of the prediction models are given below.
Prediction models
For this study we considered three prediction models in which the
ﬁrst two models only consider main effects, while the last one also
considers the interaction between marker genotypes and environments.
All models assumed that the components were random effects. For all
the models, we treated grain yield as the response. We used these
prediction models to evaluate the different sparse testing scenarios, and
the prediction accuracy (deﬁned as the Pearson correlation coefﬁcient)
was used to compare the models’ performance.
Model 1 – Environment and genotype main effects (M1: E+L):
Consider that yij represents the phenotypic value of the jth genotype/
line in the ith environment and can be explained as the sum of an

Figure 4 Maize data set DST1. Percent of
the unexplained variance (residual variance) for the 3 models M1 (E+L), M2
(E+L+G), and M3 (E+L+G+GE) for different composition of the non-overlapped/
overlapped allocation designs. Shaded
areas represent the interval of the mean
plus minus one standard deviation.

overall mean (m), a random effect of the ith environment (Ei ), a
random effect of the jth genotype/line (Lj ) plus a random error term
(eij ) capturing the variability not explained by the previous model
terms. Also consider that all random effects follow independent and
iid
identically (iid) normal distributions such that Ei  Nð0; s2E Þ,
iid
iid
2
2
Lj  Nð0; sL Þ; and eij  Nð0; se Þ: Thus, the model derived from
the previous assumptions can be written as follows:
yij ¼ m þ Ei þ Lj þ eij :

(2)

main motivation for keeping both effects, Lj and gj ; in model M2 is to
account for, as much and as best as possible, imperfect marker
information.
Model 3 – Environment, genotype, genomic, and genomic 3
environment interaction effects (M3: E+L+G+GE): By adding the
interaction between markers and environments (gEij ) to M2, the
model becomes
yij ¼ m þ Ei þ Lj þ gj þ gEij þ eij ;

Model 2 – Environment, genotype, and genomic main effects (M2:
E+L+G): This model is an extension of M1; it considers the inclusion
of the genomic information (marker SNPs) of the genotypes via the
score gj , which represents the genetic value of the jth genotype/line.
This model component can be deﬁned by the regression on p marker
p
P
xjm bm , where xjm is the genotype of the jth gecovariates gj ¼
m¼1

notype/line at the mth marker, and bm is the effect of the mth marker.
iid
Assuming that bm  Nð0; s2b Þ (m=1,. . .,p), with s2b being the variance
of the marker effects, the vector g ¼ ðg1 ; . . . ; gJ Þ0 follows a multivariate normal density with zero mean and variance-covariance
’
matrix CovðgÞ ¼ Gs2g . The term G}XX
p is the genomic relationship
matrix and it corresponds to the matrix computed using method 1, as
proposed by VanRaden (2008). The entries of the G matrix describe
the genomic similarities between pairs of genotypes, X is the standardized (by columns) matrix of molecular markers and s2g ¼ ps2b is
the genomic variance. The resulting model is
yij ¼ m þ Ei þ Lj þ gj þ eij

(3)

with g ¼ fgj g, the vector of genomic effects, following a normal
density Nð0; Gs2g Þ and the other terms are as previously deﬁned.
This model allows the borrowing of information between genotypes
via the matrix of genomic similarities, which makes it possible to
predict genotype performance of untested genotypes across environments. This is useful for all the different non-overlapping/overlapping sets, but in particular in those cases where the number of
common genotypes across environments increases (i.e., NO/all O,
as well as the intermediate cases). It should be pointed out that the

(4)

where the gEij term corresponds to the interaction between the
genetic value of the jth genotype in the ith environment. This interaction term is assumed to follow a multivariate normal distribution
0
0
such that gE  Nð0; ðZgGZg ÞðZ E Z E Þs2gE Þ (Jarquín et al. 2014b).
Matrices Zg and Z E are the incidence matrices for connecting
phenotypes with genotypes and the environments, respectively,
s2gE is the variance component of gEij , and ‘’ represents the
Hadamard product (element-by-element product) between the
two matrices.
Prediction assessment by cross-validation considering
non-overlapping/overlapping genotypes
in environments
In order to assess the levels of predictive ability that can be accomplished using different strategies (design-model combinations), a
cross-validation study is conducted. The phenotypic information
for all the genotype-in-environments combinations is known and
a portion of these are masked as missing values according to the
different designs.
Cross-validation scheme CV2 evaluates the prediction accuracy of
models when some genotypes have been evaluated in some environments but not in others. Here, the information from related genotypes
(genomic similarities) and correlated environments (replicates) is
included, and thus the predictive ability beneﬁts from borrowing
information from genotypes within an environment, from genotypes
across environments, and from correlated environments (Burgueño
et al. 2012). On the other hand, CV1 corresponds to the case where
certain percentages of genotypes were never tested and are predicted
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Figure 5 Maize data set DST2. Percent of
the unexplained variance (residual variance) for the 3 models M1 (E+L), M2
(E+L+G), and M3 (E+L+G+GE) for different composition of the non-overlapped/
overlapped allocation designs. Shaded
areas represent the interval of the mean
plus minus one standard deviation.

by other genotypes that were ﬁeld evaluated. Our NO/O allocation
schemes studied the gradual changes from the CV2 scheme to the
CV1 scheme via the random cross-validations by making small
changes in the number of non-overlapped and overlapped genotypes
in environments.
For example, the described procedure for allocating the testing set
in environments depicted in Figure 1 (where non-overlapped sets
were considered) is a particular case of the CV2 scheme where the
genotypes were observed in only one environment (zero NO/all O); it
corresponds to the diagonal of the matrix depicted in Table 1. The
procedure in Figure 3 is another particular case of the CV2 scheme,
where around 14% (41/281 · 100) of the genotypes was observed
across all environments. In this study, we considered a comprehensive and exhaustive overlapping set of the genotypes across
environments varying between 3.6% (almost all NO) and 99.6%
(almost all O).
The random cross-validation scheme, CV1, considers the problem
of predicting ‘newly’ developed genotypes/lines that have not yet been
observed in any ﬁeld. Here, the prediction accuracy relies mostly on
the genomic relationships between genotypes in the testing and
prediction sets. Figure 2 provides an example of this scheme where
a common set of 280 genotypes was observed across environments.
Although in this study we did not target this CV1 scheme, results
derived from the last column in Table 1 could lead to similar
outcomes because the levels of non-overlapping genotypes are reduced or close to being null (less than 1%). Thus, Table 1 shows
extensions of CV1 and CV2 applied to cases with different NO/O
allocation.
The prediction accuracy was measured on a trial basis as the
Pearson correlation coefﬁcient between the observed (BLUEs) and
predicted values within environments. For data sets DST1 and DST2,
the sample sizes of the genotypes in the prediction set within
environments were different: 562 (843-281) (in DST1) and
302 (453-151) (in DST2).
Data availability
The phenotype and genotype data from the genotypes crossed with
the testers (data sets DST1 and DST2), as well as other complete tables
with the genomic-enabled prediction accuracy in each of the three
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environment for DST1 and DST2, can be downloaded from the
following link http://hdl.handle.net/11529/10548369
Software
The genomic prediction analyses were computed using R and
the models were ﬁtted using the BGLR package (Pérez and de los
Campos 2014).
RESULTS
Due to the extensive case for combining different repetitions (25),
allocation sizes and composition of the NO/O allocation combinations, as well as different sizes of the initial populations, we present
the mean of the results obtained with the largest allocation set (NO/O
allocation compositions) for both data sets including all three prediction models in Figures 4-7. Detailed results for all of the different
sizes are provided in Figures A1-A4 in the Appendix. Also, to make
the presentation of the results clear and readable, we present the
average of the mean accuracies across the three environments. The
results regarding the percentage of the unexplained variance (residual
variance) by the three models, and the corresponding interval of the
mean plus or minus one standard deviation are presented as the mean
of these components across the 25 repetitions for all cases.
Percentage of unexplained variance (residual variance)
resulting from the three prediction models
The average percentage of the unexplained variability (residual
variance) from M1-M3 are displayed in Figures 4 and A1 (DST1)
and Figures 5 and A2 (DST2). The variance components were
computed for each of the repetitions (25) and the combinations of
the calibration set size - different NO/O allocation designs. For DST1
and DST2, the trends of the percentage of unexplained variance of the
total variance showed differences as well as similarities across different allocation designs.
The patterns of the unexplained variance changed slightly with the
testers. The residual variance from model M1 was small (89%)
when each maize genotype was observed once across environments
(left-hand side of the plots). Nevertheless, when the ratio of NO/O
genotypes decreased (the number of common maize genotypes in the
testing set was increased) (middle and right-hand sides of Figures 4-5

Figure 6 Maize data set DST1. Average
Pearson’s correlation between the observed and predicted values of the maize
genotypes for the 3 models M1 (E+L), M2
(E+L+G), and M3 (E+L+G+GE) for different composition of the non-overlapped/
overlapped allocation designs. Shaded
areas represent the interval of the mean
plus minus one standard deviation.

and A1-A2), the percentage of unexplained variability of M1 consistently increased for both testers (1415%).
The associated residual variance from M2 had a similar trend
showing slightly larger values than M1 in most cases. The residual
variance of M2 varied between 8% and 16% for both data sets (DST1
and DST2). Model M3 returned the smaller percentage of residual
variance in both data sets (DST1 and DST2). These values varied
between 7% and 10% of the total variance.
As for the effect of the size of the allocation design (thick lines vs.
thin lines of the same color in Figures A1-A2), in general, the residual
variance of the M3 model (thick green line vs. thin green lines)
showed that green lines slightly increased the unexplained variance
when more maize genotypes are common in all environments (lower
ratio of NO/O genotypes when moving to the right-hand side of
Figures A1-A2). Also, for model M3, the residual variance showed a
smaller increase when reducing the sample size (green thin lines)
compared with models M1 and M2.
Genome-based prediction accuracy of the various
allocation designs
Figure 6 and Table 2 (for DST1), and Figure 7 and Table 3 (for DST2)
show the average prediction accuracy across 25 replicates and all
environments. Due to the large number of cases for training set size
and set composition, in Table 2 we only use the headers of the largest
data set; the information of the exact training composition can be
found in Table 1.
For DST1, results showed the clear superiority of model M3
(green line) over models M1 (black line) and M2 (blue line) in terms
of prediction accuracy. This superiority was accomplished for all
combinations of allocation designs (NO/O). For models M2 and M3,
the prediction accuracy tends to increase as the ratio of NO/O
becomes smaller. For example, for model M3, the genomic-enabled
prediction accuracies at allocation combinations of 281/0, 141/140,
and 1/280 were 0.340, 0.376 and 0.396, respectively (Table 2).
Regarding the sample size of the calibration sets (Figures A3-A4),
when the number of genotypes evaluated in each environment decreased (251, 211, 181, 141), the genome-based prediction also decreased; however, a slight increasing trend was observed when more

genotypes were commonly tested in all environments (reducing the
NO/O ratio).
Similar trends in genome-based prediction accuracy were found
for the data set involving maize tester T2. There is a clear superiority
in terms of prediction accuracy of model M3 (green line) over models
M1 (black line) and M2 (blue line) (Figure 7) for the same combinations of allocation designs (NO/O). For model M2 and M3, the
genomic-enabled prediction accuracy increases as the ratio of NO/O
genotypes decreases. For example, for model M3, the genomicenabled prediction accuracies with allocation combinations 151/0,
81/70, and 1/150 were 0.506, 0.563, and 0.593, respectively (Table 3).
When the sample size of the genotypes evaluated in each environment decreased (131, 111, 91, 81) (Figure 7 and Table 3), the genomebased prediction for models M2-M4 remained practically unchanged
with an increasing trend when reducing the NO/O ratio. This increase
was more pronounced for M2 than for M3; however, M3 always
delivered the best results.
In summary, for the two maize data sets, DST1 and DST2, the
GE model M3 was the best predictive model. These results were
inﬂuenced by the size and composition of the allocation designs
because there is a trend of increasing prediction accuracy as the
number of common genotypes evaluated in environments increases, and there is a trend of decreasing accuracy when the
sample size of the genotypes evaluated decreases, especially with
DST1. The prediction accuracy for the DST2 data set for model
M3 reached almost 0.6 when all genotypes in the calibration set
were tested in all three environments. For both data sets DST1 and
DST2, prediction accuracies of models M1 and M2 were consistently lower than those achieved by model M3; however, also for
model M2, the prediction accuracy increased when the NO/O ratio
decreased.
These results suggest that it is better to have allocation designs
consisting of a group of common genotypes repeated in all environments than to establish groups of different genotypes evaluated in all
environments. Perhaps a common set of between 30 to 40 genotypes would provide acceptable improvements in predictive ability
without the burden of seed availability. Obviously, this will depend,
among other things, on the trait, the total number of genotypes and
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n■ Table 2 Maize tester T1. Average (across 3 environments) Pearson correlations (for 25 replicates) between the observed and predictive
values for 3 models (M1-M3) for different sizes and composition of the non-overlapped/overlapped allocation design
M1 = E+L
281
251
211
181
141
M2 = E+L+G
281
251
211
181
141
M3 = E+L+G+GE
281
251
211
181
141

281/0

251/30

211/70

181/100

141/140

101/180

51/230

1/280

0.086

0.081
0.076

0.070
0.067
0.061

0.066
0.059
0.059
0.060

0.069
0.059
0.052
0.061
0.062

0.058
0.057
0.054
0.058
0.060

0.041
0.046
0.060
0.056
0.036

20.008
0.032
0.048
0.036
0.036

0.142

0.186
0.139

0.203
0.189
0.139

0.213
0.201
0.184
0.141

0.228
0.215
0.200
0.188
0.152

0.233
0.227
0.208
0.200
0.193

0.240
0.233
0.221
0.211
0.193

0.249
0.239
0.226
0.217
0.206

0.340

0.353
0.329

0.363
0.345
0.321

0.368
0.353
0.335
0.312

0.376
0.361
0.346
0.329
0.304

0.381
0.368
0.351
0.338
0.313

0.386
0.370
0.367
0.352
0.322

0.396
0.379
0.366
0.353
0.338

environments, and the availability of resources in general (phenotyping and genotyping costs).
DISCUSSION
Genomic-assisted breeding enables breeders to select genotypes in a
better and more informed way with the main objective of increasing
the expected genetic gain. This methodology has been described by
many authors (Meuwissen et al. 2001; VanRaden 2008; de los
Campos et al. 2009; Crossa et al. 2010). Some authors have explored
the effects on predictive ability by varying the sample size of testing
sets for a prediction set of ﬁxed size for simulated (Lorenz 2013) and
real data (Burgueño et al. 2012; Jarquín et al. 2014a). Other studies
have considered the optimization of resources in multiple environments by blocking the GE interaction including mega-environments
(González-Barrios et al. 2019) and spatial adjustments of phenotypes.
However, in real applications, it is difﬁcult to know the soil conditions
in advance and successfully replicate the outcomes derived from these

adjustments. To our knowledge, this is the ﬁrst study that systematically assesses the effects on genomic-enabled predictive ability due
to allocation designs where a certain number of different genotypes is
distributed in different environments (non-overlapping) and another
set of genotypes is repeatedly observed in all the environments
(overlapping).
Results for both data sets measured for genomic prediction
accuracy indicated that substantial savings could be achieved by
overlapping a small number of genotypes in all environments
(30 and 40) and allocating the rest of the genotypes in a nonoverlapping design (NO = 251 and 111, respectively in these two data
sets, Figures 6 and A3 and Figures 7 and A4) in different environments, especially when using the GE model (M3). This study showed
that the prediction accuracy of GP increased or was stabilized when
the ratio of the NO/O genotypes decreased. Clearly, the statistical
model that included the GE component (M3) leveraged the information of genotypes tested in the target environments as well as in

Figure 7 Maize data set DST2. Average
Pearson’s correlation between the observed and predicted values of the maize
genotypes for the 3 models M1 (E+L), M2
(E+L+G), and M3 (E+L+G+GE) for different composition of the non-overlapped/
overlapped allocation designs. Shaded
areas represent the interval of the mean
plus minus one standard deviation.
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n■ Table 3 Maize tester T2. Average (3 environments) Pearson correlations (for 25 replicates) between the observed and predictive values
for 3 models (M1-M3) for different sizes and composition of the non-overlapped/overlapped allocation design
M1 = E+L
151
131
111
91
81
M2 = E+L+G
151
131
111
91
81
M3 = E+L+G+GE
151
131
111
91
81

151/0

131/20

111/40

91/60

81/70

51/100

31/120

1/150

0.250

0.236
0.217

0.224
0.203
0.155

0.205
0.193
0.141
0.089

0.181
0.173
0.125
0.096
0.101

0.152
0.150
0.104
0.105
0.104

0.116
0.129
0.095
0.106
0.101

0.029
0.099
0.100
0.091
0.075

0.367

0.426
0.383

0.459
0.441
0.386

0.474
0.471
0.445
0.371

0.489
0.485
0.471
0.442
0.430

0.499
0.498
0.485
0.469
0.463

0.510
0.506
0.493
0.486
0.478

0.523
0.516
0.507
0.496
0.491

0.506

0.526
0.517

0.543
0.533
0.516

0.553
0.548
0.534
0.505

0.563
0.558
0.541
0.530
0.526

0.570
0.565
0.555
0.541
0.538

0.581
0.570
0.556
0.555
0.548

0.593
0.573
0.566
0.561
0.552

other environments. In this case, signiﬁcant cost savings and increase
in genome-based accuracy can be achieved by testing more common
genotypes in all the environments with model M3. The M3 model
offers the advantage of returning accurate predictions for diverse
calibration set compositions. The composition of the calibration sets
depends on the seed availability for establishing trials in breeding
programs, among other factors. Thus, we can state that M3 easily
adapts to the seed availability of the breeding programs when designing and planning ﬁeld trials. This model also offers the advantage
of increasing the capacity of evaluation of genotypes by delivering
similar levels (moderate to high) of predictive ability with reduced
sample sizes, allowing savings of resources (ﬁeld, phenotyping cost,
water use, etc.).
For example, for DST1, testing the same 280 maize genotypes in
each of the 3 environments, and for DST2, testing the same 151 genotypes in the 3 environments produced higher prediction accuracy
than other allocation methods using a GP model that includes the GE
component (M3). However, researchers might like to include a small
proportion of common genotypes across all environments to estimate
the environmental variance (not to be confounded with the genotype
variance) or, due to logistics, they might not have the desired
materials to test in these environments but they might be evaluated
in others.
In both maize data sets, the decrease in the size of the training set
represented by thin lines (in the ﬁgures) had, as expected, a negative
effect on the prediction accuracy, but when the ratio of NO/O
genotypes decreased, the predictive ability of the models increased
within the same training set sizes. These results can be explained by
the smaller patterns of residual variance showed by M3 for the DST1
and DST2 data sets.
Predictive ability of the models used in this study
One objective of this research was to study different strategies for how
to increase predictive ability by using allocation methods of genotypes
with different proportions of NO/O in environments in conjunction
with models that capture GE variance from the different sparse
allocation testing designs. In model M1, for the disjointed partition
(NO/O) (281/0 for DST1 and 151/0 for DST2), the effect of environments is confounded with the genotype effect; thus the prediction

of an unobserved genotype in a particular environment is mainly
inﬂuenced by the single observation (replicate) of that genotype but
measured in a different environment. For model M1, the percentage
of unexplained variance increased for low values of NO/O. Prediction
accuracies followed opposite trends; as the residual variance of M1
increased, when the NO/O proportion decreased, the predictive
ability rapidly decreased.
The percentage of unexplained variance of model M2 including
genotypes and genomic information was the highest for both data sets
for almost all of the cases (training set size and training composition),
and the genomic-enabled prediction accuracy was intermediate between model M1 and model M3. In general, DST2 gave higher
prediction accuracy than DST1. The main reason why model M3
was always the best predictive model resides in the fact that the GE
interaction term reduced the unexplained proportion of the total
variance signiﬁcantly compared with the other models (M1 and
M2). Also, the GE term from model M3 allows the borrowing of
information from related genotypes evaluated in correlated
environments.
It is possible to use other prediction models to leverage the GE
interaction in prediction models for predicting unobserved genotypes. For example, the factor analytic model is a parsimonious model
(Burgueño et al. 2012) for capturing the genetic correlations among
environments. In addition, in this study, we used only genomic
information, but it may be possible to add pedigree information,
incorporated into M3; thus a slight increase in the prediction
accuracy of the unobserved genotypes in the designs with different
allocations can be still expected.
Furthermore, the type of marker system data (technology, platform, number of markers, cost, etc.) plays a relevant role in the
assessment of sparse testing for genomic-enabled prediction. The
high-density marker data used in this study (68,169 and 62,882 SNP
markers for DST1 and DST2, respectively) were suitable for delivering appropriate genomic-enabled prediction accuracy. However,
in a more realistic scenario, the cost of the markers must be also
considered besides the total plot unit cost. Perhaps a high-density
marker set becomes costly, and possibly a much lower marker density
set would be necessary to stay within the boundaries of the budget. If
the marker platform changes to low density, new studies will have to
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be conducted to consider their prediction accuracy as well as their
total costs.
Importance of sparse testing methods for
genomic selection
As previously pointed out, there are different ways to study resource
allocation in sparse testing. Obviously, plant breeding programs have
limited ﬁnancial resources per plot unit; thus, it is of paramount
importance to plant only a limited number of plots while optimizing
the molecular and ﬁeld evaluation resources with the objective of
increasing genetic gains. Therefore, given the ﬁxed costs, breeders
must study how many genotypes could be genotyped and how many
of the total genotypes could be evaluated in the ﬁeld, with the
objective of designing allocation methods that save resources while
increasing genetic gains. Some researchers aim to test more genotypes
by using a sparse testing allocation method that focuses on increasing the intensity of selection, thus optimizing the response to
selection. Other researchers aim for maximizing the genetic gains
with a ﬁxed plot unit cost but without increasing the intensity of
selection, as enlarging ﬁeld trials will inevitably increase the phenotyping costs.
Also, as pointed out, sparse testing schemes focusing on increasing
the intensity of selection by increasing the number of testing genotypes will also increase the ﬁnal genetic gains. Our study is directly
related to increases in genetic gains because we show how the genetic
and GE variance components change with different NO/O; however,
our study did not directly assess increasing the intensity of selection
as a factor for increasing genetic gains. Our study did not directly
study the effect of an un-replicated (augmented) design in terms of
costs inﬂuencing the NO/O ratio. However, some factors must be
considered. One aspect of un-replicated designs is that they facilitate
the increase in population size and thus the intensity of selection, but
at the cost of diminishing the estimation precision. Another factor of
un-replicated designs is the necessary balance between plots assigned
to un-replicated entries vs. plots with replicated entries (or checks).
Genomic-enabled prediction accuracy usually requires good and
extensive phenotype data of the genotypes in the testing set.
CONCLUSIONS
In this study, we evaluated the genomic-enabled prediction accuracy
in different ﬁeld sparse testing systems consisting of different ratios of
NO/O genotypes included in environments. The results indicated
that the genome-based model including GE captured more phenotypic variability (smaller residual variance) than the main effects
models. In addition, the GE genomic model provided higher prediction accuracy than the main effects models in the different
allocation designs comprising different combinations of NO/O genotypes in environments. Reducing the size of the testing populations
slightly decreased the accuracy; however, the levels of predictive
ability were recovered when we increased the number of common
genotypes tested across environments. The GE model (M3) offers the
possibility of maintaining the prediction accuracy when the two
extreme situations occur [(1) all non-overlapping genotypes and
(2) all overlapping genotypes)] while reducing the size of the training
set. Results indicated that substantial savings of testing resources
could be achieved by optimizing the allocation design using genomebased models including GE interaction. For the given sizes of the
trials included in this study, it is recommended (but not necessary)
to have a small proportion of genotypes overlapping in all the
environments while a large proportion of genotypes should be nonoverlapping in the environments.
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APPENDIX
Allocation designs varying the number of tested genotypes in different environments

Figure A1 Maize data set DST1. Percent of
the explained variance (residual variance) for
the 3 models M1 (E+L), M2 (E+L+G), and M3
(E+L+G+GE) for different sizes and compositions of the non-overlapped/overlapped
allocation designs. Thick lines represent
the mean using the largest possible sample
size for model calibration (281) for different
compositions. The thinner lines represent
the mean for the reduced/smaller sample
sizes (281-141 in steps of 10).

Figure A2 Maize data set DST2. Percent
of the unexplained variance (residual variance)
for the 3 models M1 (E+L), M2 (E+L+G), and
M3 (E+L+G+GE) for different sizes and compositions of the non-overlapped/overlapped
allocation designs. Thick lines represent the
mean using the largest possible sample size
for model calibration (151) for different compositions. The thinner lines represent the
mean for the reduced/smaller sample sizes
(151-81 in steps of 10).
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Figure A3 Maize data set DST1. Average
Pearson’s correlation between the observed
and predicted values of the maize genotypes
for the 3 models M1 (E+L), M2 (E+L+G), and
M3 (E+L+G+GE) for different sizes and compositions of the non-overlapped/overlapped
allocation designs. Thick lines represent the
mean using the largest possible sample size
for model calibration (281) for different compositions. The thinner lines represent the
mean for the reduced/smaller sample sizes
(281-141 in steps of 10).

Figure A4 Maize data set DST2. Average
Pearson’s correlation between the observed
and predicted values of the maize genotypes
for the 3 models M1 (E+L), M2 (E+L+G), and
M3 (E+L+G+GE) for different sizes and compositions of the non-overlapped/overlapped
allocation designs. Thick lines represent the
mean using the largest possible sample size
for model calibration (151) for different compositions. The thinner lines represent the
mean for the reduced/smaller sample sizes
(151-81 in steps of 10).
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